Athersys, Inc.
Cleveland, OH, US· latest recorded location
Athersys, Inc. is named on 32 US grants and 33 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 32
- Published applications
- 33
- Inventors
- 40
- Granted in 2026 so far
- 0
- Most recent grant
- 11 May 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 2 | 0 |
| 2003 | 6 | 2 |
| 2004 | 1 | 9 |
| 2005 | 1 | 1 |
| 2006 | 1 | 1 |
| 2007 | 0 | 4 |
| 2008 | 3 | 1 |
| 2009 | 1 | 4 |
| 2010 | 2 | 2 |
| 2011 | 6 | 4 |
| 2012 | 3 | 2 |
| 2013 | 0 | 0 |
| 2014 | 2 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 2 | 3 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
By publication year.
Technology areas
Share of 65 documents
- A61PTherapeutic uses of medicines37
- A61KMedicines and medical preparations36
- C12NMicroorganisms or enzymes34
- C07DHeterocyclic compounds26
- C07KPeptides16
- A61NElectrotherapy9
- C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms7
- G01NInvestigating or analysing materials by determining their chemical or physical properties3
- A01KAnimal husbandry1
- C07HSugars1
Recent patents
- Immunomodulatory properties of MAPCs and uses thereof11 May 2021US 11,000,546 B2
- MAPC treatment of brain injuries and diseases6 Nov 2018US 10,117,900 B2
- Immunomodulatory properties of multipotent adult progenitor cells and uses thereof8 May 2018US 9,962,407 B2
- Immunomodulatory properties of multipotent adult progenitor cells and uses thereof7 Nov 2017US 9,808,485 B2
- Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof6 May 2014US 8,716,276 B2
- Immunomodulatory properties of mapcs and uses thereof8 Nov 2018US 2018/0318346 A1
- Mapc treatment of brain injuries and diseases3 May 2018US 2018/0117093 A9
- Immunomodulatory properties of multipotent adult progenitor cells and uses thereof1 Mar 2018US 2018/0055881 A1
- Tricyclic Indeno-Pyrrole Derivatives as Serotonin Receptor Modulators4 Oct 2012US 2012/0252859 A1
- Immunomodulatory properties of multipotent adult progenitor cells and uses thereof31 May 2012US 2012/0135043 A1
Most cited
By later US patents
- Immunomodulatory properties of multipotent adult progenitor cells and uses thereof43US 8,147,824 B22012
- Compositions and methods for non-targeted activation of endogenous genes26US 6,361,972 B12002
- Compositions and methods for non-targeted activation of endogenous genes25US 6,410,266 B12002
- Compositions and method for non-targeted activation of endogenous genes12US 6,602,686 B12003
- Compositions and methods for non-targeted activation of endogenous genes12US 6,623,958 B12003